Nuo Therapeutics, Inc. (AURX) — 8-K Filings

8-K Filings (8)

• 8-K Filing — Dec 17, 2025
• Nuo Therapeutics Files 8-K on Officer/Director Changes — Oct 10, 2025 Risk: medium
  Nuo Therapeutics, Inc. filed an 8-K on October 10, 2025, reporting events as of October 7, 2025. The filing indicates changes related to the departure of direct
• Nuo Therapeutics Enters Material Definitive Agreement — May 15, 2025 Risk: medium
  Nuo Therapeutics, Inc. announced on May 14, 2025, that it entered into a material definitive agreement. The filing does not provide specific details about the a
• Nuo Therapeutics Files 8-K: Material Agreement & Equity Sales — Sep 19, 2024 Risk: medium
  Nuo Therapeutics, Inc. entered into a material definitive agreement on September 18, 2024. The company also reported on unregistered sales of equity securities
• Nuo Therapeutics Files 8-K for Other Event — Jun 27, 2024 Risk: medium
  Nuo Therapeutics, Inc. filed an 8-K on June 27, 2024, reporting an "Other Event." The filing does not contain specific details about the event, its financial im
• Nuo Therapeutics Changes Auditors to EisnerAmper LLP — Jun 11, 2024 Risk: medium
  Nuo Therapeutics, Inc. announced on June 7, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public ac
• Nuo Therapeutics Files 8-K: Material Agreement & Financials — May 21, 2024 Risk: medium
  On May 17, 2024, Nuo Therapeutics, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and f
• Nuo Therapeutics Files 8-K for Regulation FD Disclosure — Apr 16, 2024 Risk: low
  Nuo Therapeutics, Inc. filed an 8-K on April 16, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX